Ultime notizie per N2OFF (NASDAQ:NITO) Azioni

N2OFF

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.

N2OFF Inc

NITORI HOLDINGS CO LTD by Nitori Holdings Co., Ltd.

Nitori Holdings Co Ltd

NITORI HOLDINGS CO U/ADR by Nitori Holdings Co., Ltd.

WIIM

ERII

Energy Recovery shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, B. Riley Securities downgraded the stock from Buy to Neutral and lowered its price target from $20 to $12.5

<p>RBC Capital  analyst Arun Viswanathan   maintains Ball (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>) with a Outperform and raises the price target from $62 to $63.</p>


News

Price Target

Analyst Ratings

BALL

RBC Capital Maintains Outperform on Ball, Raises Price Target to $63

<p>Barclays  analyst Trevor Young   maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Overweight and raises the price target from $2500 to $3100.</p>


MELI

Barclays Maintains Overweight on MercadoLibre, Raises Price Target to $3100

<p>Barclays  analyst Benjamin Budish   maintains MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) with a Equal-Weight and raises the price target from $232 to $240.</p>


MKTX

Barclays Maintains Equal-Weight on MarketAxess Holdings, Raises Price Target to $240

<p><strong>JPMorgan </strong>analyst Arun Jayaram anticipates a neutral market reaction to <strong>Occidental Petroleum Corp. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) <a href="https://www.benzinga.com/quote/OXY/analyst-ratings">earnings</a>.</p>
<p>Jayaram explained in a Thursday research note that positive results, debt reduction, and cost-saving initiatives were partly offset by potential risks to full-year guidance related to U.S. operating expenses and Gulf of Anadarko (GoA) volumes.</p>
<p>Jayaram&#8217;s forecast comes after Occidental reported adjusted EPS of 87 cents per share, which beat the analyst consensus estimate of 77 cents and revenue of $6.84 billion, which missed the analyst <a href="https://www.benzinga.com/25/05/45290926/occidental-beats-q1-profit-forecast-slashes-debt-by-23-billion-year-to-date" target="_blank" rel="noreferrer noopener">consensus estimate of $6.89 billion</a>.</p>
<p>The company sees production of 1,377 – 1,417 Mboed in the second quarter and 1,390 – 1,440 Mboed&nbsp;<a href="https://www.oxy.com/siteassets/documents/investors/quarterly-earnings/oxy1q25conferencecallslides.pdf" target="_blank" rel="noreferrer noopener">in&nbsp;</a>FY25.</p>
<p>Occidental also slashed the mid-point of 2025 capital guidance by $200 million and domestic operating costs by $150 million, on continued operational efficiency gains and schedule optimization <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">in the Permian and Gulf of America</a>.</p>
<p>So far, second-quarter 2025 guidance slightly trails JPMorgan expectations.</p>
<p>Jayaram notes that Occidental anticipates total production volumes in the GoA to reach 142 thousand barrels of oil equivalent per day (MBoe/d) for 2025.</p>
<p>Achieving this target would necessitate a significant increase in production during the second half of the year to approximately 158 MBoe/d, which is about 26% higher than the projected first-half 2025 average of 126 MBoe/d, adds the analyst.</p>
<p>Jayaram considers this a challenging goal, especially given the reduced capital allocation to offshore projects.</p>
<p>The analyst estimates the second-quarter total production of 1,413 Mboed (vs. street view of 1,420 Mboed) and FY25 production of 1,415 Mboed (same as consensus).</p>
<p>Investors can gain exposure to the stock via&nbsp;<strong>Texas Capital Funds Trust Texas Capital Texas Oil Index ETF&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OILT#NYSE">OILT</a>) and&nbsp;<strong>First Trust Nasdaq Oil &amp; Gas ETF&nbsp;</strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXN#NASDAQ">FTXN</a>).</p>
<p><strong>Price Action: </strong>OXY shares are up 6.11% at $41.40 at the last check on Thursday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com//node/45284262" target="_blank" rel="noreferrer noopener">Exxon Mobil Says Deal With Japan&#8217;s Marubeni To Boost Global Energy Supply</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Equities

Large Cap

Movers

FTXN

OILT

Neutral Territory For Occidental? JPMorgan Weighs Strong Q1 Against Future Challenges

<p>Telos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) will release its quarterly earnings report on Friday, 2025-05-09. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Telos to report an <strong>earnings per share</strong> (EPS) of $-0.05.</p>
<p>The market awaits Telos's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>During the last quarter, the company reported an EPS beat by $0.05, leading to a 0.38% drop in the share price on the subsequent day.</p>
<p>Here's a look at Telos's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.09</td>
<td>-0.14</td>
<td>-0.14</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.04</td>
<td>-0.10</td>
<td>-0.09</td>
<td>-0.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-5.0%</td>
<td>-47.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723775_0.png" alt="eps graph" /></p>
<h3>Telos Share Price Analysis</h3>
<p>Shares of Telos were trading at $2.49 as of May 07. Over the last 52-week period, shares are down 27.63%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Insights on Telos</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Telos.</p>
<p>Analysts have provided Telos with 3 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $3.83, suggesting a potential 53.82% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Silvaco Group, Duos Technologies Group and Arteris, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Silvaco Group, with an average 1-year price target of $17.0, suggesting a potential 582.73% upside.</li>
<li>Analysts currently favor an Buy trajectory for Duos Technologies Group, with an average 1-year price target of $9.0, suggesting a potential 261.45% upside.</li>
<li>Analysts currently favor an Buy trajectory for Arteris, with an average 1-year price target of $15.33, suggesting a potential 515.66% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Silvaco Group, Duos Technologies Group and Arteris, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Telos</td>
<td>Neutral</td>
<td>-35.77%</td>
<td>$10.62M</td>
<td>-7.27%</td>
</tr>
<tr>
<td>Silvaco Group</td>
<td>Buy</td>
<td>43.03%</td>
<td>$15.44M</td>
<td>4.18%</td>
</tr>
<tr>
<td>Duos Technologies Group</td>
<td>Buy</td>
<td>-4.27%</td>
<td>$-329.95K</td>
<td>-142.71%</td>
</tr>
<tr>
<td>Arteris</td>
<td>Buy</td>
<td>23.87%</td>
<td>$13.91M</td>
<td>-1607.05%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Telos ranks at the bottom for Revenue Growth and Gross Profit, indicating negative growth and profit. It also has the lowest Return on Equity among its peers, reflecting poor performance in generating profit from shareholders' equity. Overall, Telos lags behind its peers in key financial metrics.</p>
<h3>Get to Know Telos Better</h3>
<p>Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.</p>
<h3>Unraveling the Financial Story of Telos</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Challenges:</strong> Telos's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-35.77%</strong>. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> Telos's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-35.38%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Telos's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-7.27%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Telos's ROA excels beyond industry benchmarks, reaching <strong>-5.75%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.08</strong>, Telos adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/TLS/earnings"><strong>To track all earnings releases for Telos visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

What's Next: Telos's Earnings Preview

<p>Rapid Micro Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPID#NASDAQ">RPID</a>) is preparing to release its quarterly earnings on Friday, 2025-05-09. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Rapid Micro Biosystems to report an <strong>earnings per share</strong> (EPS) of $-0.27.</p>
<p>The announcement from Rapid Micro Biosystems is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.00, leading to a 0.0% drop in the share price the following trading session.</p>
<p>Here's a look at Rapid Micro Biosystems's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.22</td>
<td>-0.25</td>
<td>-0.28</td>
<td>-0.29</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.22</td>
<td>-0.26</td>
<td>-0.29</td>
<td>-0.31</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>2.0%</td>
<td>17.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723764_0.png" alt="eps graph" /></p>
<h3>Rapid Micro Biosystems Share Price Analysis</h3>
<p>Shares of Rapid Micro Biosystems were trading at $2.32 as of May 07. Over the last 52-week period, shares are up 215.0%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Views on Rapid Micro Biosystems</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Rapid Micro Biosystems.</p>
<p>Analysts have provided Rapid Micro Biosystems with 1 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $8.0, suggesting a potential 244.83% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Champions Oncology, Akoya Biosciences and Harvard Bioscience, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Champions Oncology, with an average 1-year price target of $12.0, suggesting a potential 417.24% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Akoya Biosciences, with an average 1-year price target of $2.19, suggesting a potential 5.6% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Harvard Bioscience, with an average 1-year price target of $4.5, suggesting a potential 93.97% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Champions Oncology, Akoya Biosciences and Harvard Bioscience, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rapid Micro Biosystems</td>
<td>Outperform</td>
<td>29.68%</td>
<td>$981K</td>
<td>-12.10%</td>
</tr>
<tr>
<td>Champions Oncology</td>
<td>Buy</td>
<td>41.77%</td>
<td>$10.42M</td>
<td>146.18%</td>
</tr>
<tr>
<td>Akoya Biosciences</td>
<td>Neutral</td>
<td>-19.42%</td>
<td>$14.39M</td>
<td>-77.25%</td>
</tr>
<tr>
<td>Harvard Bioscience</td>
<td>Outperform</td>
<td>-12.78%</td>
<td>$14.01M</td>
<td>0.03%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Rapid Micro Biosystems ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, it is at the top for Return on Equity. Overall, Rapid Micro Biosystems is positioned in the middle compared to its peers based on the provided metrics.</p>
<h3>Get to Know Rapid Micro Biosystems Better</h3>
<p>Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.</p>
<h3>Rapid Micro Biosystems's Financial Performance</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Rapid Micro Biosystems's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>29.68%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Rapid Micro Biosystems's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-117.62%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Rapid Micro Biosystems's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-12.1%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Rapid Micro Biosystems's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>-9.48%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.08</strong>, Rapid Micro Biosystems adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/RPID/earnings"><strong>To track all earnings releases for Rapid Micro Biosystems visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


RPID

Rapid Micro Biosystems's Earnings Outlook

<p>American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is preparing to release its quarterly earnings on Friday, 2025-05-09. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect American Strategic to report an <strong>earnings per share</strong> (EPS) of $-2.01.</p>
<p>American Strategic bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<p>Here's a look at American Strategic's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td></td>
<td>-2.62</td>
<td>-2.99</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-2.6</td>
<td>-2.62</td>
<td>-2.84</td>
<td>-3.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>0.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>American Strategic Share Price Analysis</h3>
<p>Shares of American Strategic were trading at $11.66 as of May 06. Over the last 52-week period, shares are up 42.8%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/NYC/earnings"><strong>To track all earnings releases for American Strategic visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Preview Of American Strategic's Earnings

<p>RBC Capital  analyst Brad Heffern   maintains AvalonBay Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) with a Sector Perform and lowers the price target from $223 to $220.</p>


RBC Capital Maintains Sector Perform on AvalonBay Communities, Lowers Price Target to $220

<p>AMC Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) is preparing to release its quarterly earnings on Friday, 2025-05-09. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect AMC Networks to report an <strong>earnings per share</strong> (EPS) of $0.81.</p>
<p>Anticipation surrounds AMC Networks's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.41, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at AMC Networks's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.05</td>
<td>0.62</td>
<td>1.52</td>
<td>1.67</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.64</td>
<td>0.91</td>
<td>1.24</td>
<td>1.16</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-11.0%</td>
<td>3.0%</td>
<td>-5.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723737_0.png" alt="eps graph" /></p>
<h3>Performance of AMC Networks Shares</h3>
<p>Shares of AMC Networks were trading at $6.63 as of May 07. Over the last 52-week period, shares are down 51.21%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/AMCX/earnings"><strong>To track all earnings releases for AMC Networks visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


AMCX

An Overview of AMC Networks's Earnings

<p>Barclays  analyst Alex Scott   maintains Jackson Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JXN#NYSE">JXN</a>) with a Overweight and raises the price target from $106 to $108.</p>


Barclays Maintains Overweight on Jackson Finl, Raises Price Target to $108

<p>1stdibs.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIBS#NASDAQ">DIBS</a>) will release its quarterly earnings report on Friday, 2025-05-09. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate 1stdibs.com to report an <strong>earnings per share</strong> (EPS) of $-0.13.</p>
<p>Anticipation surrounds 1stdibs.com's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $0.03, leading to a 0.0% drop in the share price the following trading session.</p>
<p>Here's a look at 1stdibs.com's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.17</td>
<td>-0.09</td>
<td>-0.08</td>
<td>-0.09</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.14</td>
<td>-0.15</td>
<td>-0.12</td>
<td>-0.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-8.0%</td>
<td>0.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723725_0.png" alt="eps graph" /></p>
<h3>Tracking 1stdibs.com's Stock Performance</h3>
<p>Shares of 1stdibs.com were trading at $2.61 as of May 07. Over the last 52-week period, shares are down 56.2%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/DIBS/earnings"><strong>To track all earnings releases for 1stdibs.com visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


DIBS

Exploring 1stdibs.com's Earnings Expectations

<p>Shares of <strong>Bumble Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) jumped 23.9% to $5.44 Thursday afternoon. The company on Wednesday reported mixed first-quarter results.</p>
<p><strong>What To Know:</strong> Bumble <a href="https://www.benzinga.com/pressreleases/25/05/b45265817/bumble-inc-announces-first-quarter-2025-results">posted</a> earnings of 13 cents per share, slightly below the 14 cent consensus estimate and down from 19 cents a year ago. Revenue came in at $247.1 million, narrowly beating expectations but marking a 7.7% year-over-year decline. </p>
<p>Despite softening results, CEO <strong>Whitney Wolfe Herd</strong>, who returned in March, emphasized a renewed focus on growth, innovation and operational efficiency. The company maintained a steady paying user base of around 4 million, though average revenue per user fell to $20.24 from $21.84. </p>
<p>For the second-quarter, Bumble <a href="https://www.benzinga.com/pressreleases/25/05/b45265817/bumble-inc-announces-first-quarter-2025-results">guided revenue</a> between $235 million and $243 million, below the $243.7 million consensus. Goldman Sachs responded by reaffirming a Buy rating and raising its price target from $8 to $9. </p>
<p>In a move to <a href="https://www.benzinga.com/pressreleases/25/05/b45250789/bumble-inc-appoints-new-executive-leaders">strengthen leadership</a>, Bumble also appointed <strong>Vivek Sagi</strong> as CTO, <strong>Julie Radford</strong> as Chief Communications Officer, and <strong>Deirdre Runnette</strong> as Chief Legal Officer. </p>
<p>The company also repurchased $28.7 million in shares in the first-quarter under its ongoing buyback program.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/25/05/45290579/carvana-stock-is-moving-higher-thursday-whats-going-on">Carvana Stock Is Moving Higher Thursday: What&#8217;s Going On?</a></strong></p>
<h2 class="wp-block-heading">How To Buy BMBL Stock</h2>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in Bumble&#8217;s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p>According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BMBL has a 52-week high of $12.49 and a 52-week low of $3.55.</p>


BMBL

Bumble (BMBL) Stock Surges 20% After Q1 Results: What's Going On?

<p><strong>uniQure</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) is set to give its latest quarterly earnings report on Friday, 2025-05-09. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that uniQure will report an <strong>earnings per share</strong> (EPS) of $-0.96. </p>
<p>The announcement from uniQure is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS missed by $0.99 in the last quarter, leading to a 8.95% increase in the share price on the following day.</p>
<p>Here's a look at uniQure's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.51</td>
<td>-1</td>
<td>-1.25</td>
<td>-1.33</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-1.50</td>
<td>-0.91</td>
<td>-1.16</td>
<td>-1.36</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>9.0%</td>
<td>18.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723712_0.png" alt="eps graph" /></p>
<h3>Tracking uniQure's Stock Performance</h3>
<p>Shares of uniQure were trading at $10.06 as of May 07. Over the last 52-week period, shares are up 147.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/QURE/earnings"><strong>To track all earnings releases for uniQure visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


QURE

Earnings Outlook For uniQure

<p>Outbrain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OB#NASDAQ">OB</a>) will release its quarterly earnings report on Friday, 2025-05-09. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Outbrain to report an <strong>earnings per share</strong> (EPS) of $-0.05.</p>
<p>Anticipation surrounds Outbrain's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS missed by $0.04 in the last quarter, leading to a 5.8% drop in the share price on the following day.</p>
<p>Here's a look at Outbrain's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.11</td>
<td>0.03</td>
<td>-0.09</td>
<td>-0.13</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.07</td>
<td>0.11</td>
<td>0</td>
<td>-0.10</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>-1.0%</td>
<td>-4.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723705_0.png" alt="eps graph" /></p>
<h3>Performance of Outbrain Shares</h3>
<p>Shares of Outbrain were trading at $3.37 as of May 07. Over the last 52-week period, shares are down 22.44%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Opinions on Outbrain</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Outbrain.</p>
<p>Analysts have given Outbrain a total of 4 ratings, with the consensus rating being Buy. The average one-year price target is $6.97, indicating a potential 106.82% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of  and Outbrain, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>In the peer analysis summary, key metrics for  and Outbrain are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Outbrain</td>
<td>Buy</td>
<td>-5.50%</td>
<td>$56.06M</td>
<td>2.04%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Outbrain ranks at the bottom for Revenue Growth among its peers. It also ranks at the bottom for Gross Profit. However, it is in the middle for Return on Equity.</p>
<h3>Unveiling the Story Behind Outbrain</h3>
<p>Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.</p>
<h3>Key Indicators: Outbrain's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Outbrain's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-5.5%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.</p>
<p><strong>Net Margin:</strong> Outbrain's net margin excels beyond industry benchmarks, reaching <strong>1.99%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Outbrain's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>2.04%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Outbrain's ROA excels beyond industry benchmarks, reaching <strong>0.86%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Outbrain's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.07</strong>.</p>
<p><a href="https://www.benzinga.com/quote/OB/earnings"><strong>To track all earnings releases for Outbrain visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Outbrain

Trading Ideas

LDOS

MSFT

CNBC Halftime Report Final Trades: Microsoft Corporation, Leidos Holdings, Blackstone, JP Morgan Chase & Co

<p>TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that TeraWulf will report an <strong>earnings per share</strong> (EPS) of $-0.06.</p>
<p>TeraWulf bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.05, leading to a 0.0% drop in the share price the following trading session.</p>
<p>Here's a look at TeraWulf's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.03</td>
<td>-0.03</td>
<td>0.01</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.08</td>
<td>-0.06</td>
<td>-0.03</td>
<td>-0.02</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>16.0%</td>
<td>-14.000000000000002%</td>
<td>-7.000000000000001%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723690_0.png" alt="eps graph" /></p>
<h3>TeraWulf Share Price Analysis</h3>
<p>Shares of TeraWulf were trading at $3.05 as of May 07. Over the last 52-week period, shares are up 51.79%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Observations about TeraWulf</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding TeraWulf.</p>
<p>A total of 3 analyst ratings have been received for TeraWulf, with the consensus rating being Buy. The average one-year price target stands at $6.0, suggesting a potential 96.72% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Amplitude, NCR Voyix and Sprout Social, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Amplitude, with an average 1-year price target of $14.61, suggesting a potential 379.02% upside.</li>
<li>Analysts currently favor an Buy trajectory for NCR Voyix, with an average 1-year price target of $14.33, suggesting a potential 369.84% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Sprout Social, with an average 1-year price target of $28.82, suggesting a potential 844.92% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Amplitude, NCR Voyix and Sprout Social are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>TeraWulf</td>
<td>Buy</td>
<td>63.47%</td>
<td>$15.36M</td>
<td>-9.46%</td>
</tr>
<tr>
<td>Amplitude</td>
<td>Buy</td>
<td>9.42%</td>
<td>$58.33M</td>
<td>-11.11%</td>
</tr>
<tr>
<td>NCR Voyix</td>
<td>Buy</td>
<td>-14.32%</td>
<td>$149M</td>
<td>-1.44%</td>
</tr>
<tr>
<td>Sprout Social</td>
<td>Neutral</td>
<td>14.43%</td>
<td>$83.68M</td>
<td>-8.88%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>TeraWulf ranks at the bottom for Revenue Growth and Gross Profit, while it ranks at the top for Return on Equity among its peers.</p>
<h3>Discovering TeraWulf: A Closer Look</h3>
<p>TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.</p>
<h3>TeraWulf's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, TeraWulf showcased positive performance, achieving a revenue growth rate of <strong>63.47%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> TeraWulf's net margin is impressive, surpassing industry averages. With a net margin of <strong>-80.94%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-9.46%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> TeraWulf's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-4.75%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> TeraWulf's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>2.09</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/WULF/earnings"><strong>To track all earnings releases for TeraWulf visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


WULF

Earnings Preview: TeraWulf

<p>Barclays  analyst Ross Sandler   maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Overweight and raises the price target from $86 to $97.</p>


UBER

Barclays Maintains Overweight on Uber Technologies, Raises Price Target to $97

<p>NextNav (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NN#NASDAQ">NN</a>) is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that NextNav will report an <strong>earnings per share</strong> (EPS) of $-0.14.</p>
<p>The announcement from NextNav is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.11, leading to a 9.06% increase in the share price the following trading session.</p>
<p>Here's a look at NextNav's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.14</td>
<td>-0.15</td>
<td>-0.14</td>
<td>-0.14</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.25</td>
<td>-0.11</td>
<td>-0.21</td>
<td>-0.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>9.0%</td>
<td>4.0%</td>
<td>2.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723680_0.png" alt="eps graph" /></p>
<h3>Tracking NextNav's Stock Performance</h3>
<p>Shares of NextNav were trading at $13.795 as of May 07. Over the last 52-week period, shares are up 86.45%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/NN/earnings"><strong>To track all earnings releases for NextNav visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look at NextNav's Upcoming Earnings Report

<p>Gogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) is preparing to release its quarterly earnings on Friday, 2025-05-09. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Gogo to report an <strong>earnings per share</strong> (EPS) of $0.08.</p>
<p>The announcement from Gogo is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $0.03, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at Gogo's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.09</td>
<td>0.05</td>
<td>0.07</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.06</td>
<td>0.12</td>
<td>0.09</td>
<td>0.16</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-6.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746723671_0.png" alt="eps graph" /></p>
<h3>Tracking Gogo's Stock Performance</h3>
<p>Shares of Gogo were trading at $7.53 as of May 07. Over the last 52-week period, shares are down 26.03%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/GOGO/earnings"><strong>To track all earnings releases for Gogo visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GOGO

A Look Ahead: Gogo's Earnings Forecast

Press Releases

N2OFF: Save Foods Ltd. (100%) Wins Patent Opposition Filed by ECOLAB in Europe

N2OFF and Solterra Join Forces to Exclusively Co-Develop the Solar PV Market in Albania

N2OFF and Solterra Unite to Pioneer Solar PV Development in Albania

N2OFF and Solterra Announce the Closing of a Definitive Agreement to Develop 196 MWp Battery Storage Projects in Italy

N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers

Contracts

SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers

N2OFF Establishes a US Subsidiary for Its Solar PV Operations

N2OFF Secures Definitive Agreement to Commercialize 196 MWp Battery Storage Projects

N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects

N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany

NITO

SPRC

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

Comments

N2OFF

Notizie

Ultime notizie per N2OFF (NASDAQ:NITO) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO